BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx BioInvestors Business Daily • 01/12/26
BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular RiskGlobeNewsWire • 01/12/26
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 InhibitorGlobeNewsWire • 12/04/25
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 10/02/25
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitorPRNewsWire • 09/15/25
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 InhibitorGlobeNewsWire • 08/15/25
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business UpdatesGlobeNewsWire • 08/06/25
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 07/03/25
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific SessionsGlobeNewsWire • 06/21/25
BioAge Labs Expands Drug Discovery Platform with Data from Leading European BiobankGlobeNewsWire • 06/17/25
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business UpdatesGlobeNewsWire • 05/06/25
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024GlobeNewsWire • 03/20/25
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. Lawsuit - BIOAAccesswire • 03/11/25
Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOAPRNewsWire • 03/11/25
Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BIOAAccesswire • 03/10/25
BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities LawsuitPRNewsWire • 03/10/25
Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 03/10/25
BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOAGlobeNewsWire • 03/10/25